Cadence Neuroscience, Inc.
Biotechnology company · Sammamish, Washington, United States
Cadence Neuroscience, Inc. is a biotechnology company headquartered in Sammamish, Washington, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $26 million sold in a notice filed in 2023.
Cadence Neuroscience at a glance
What does Cadence Neuroscience do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $26 million sold (2023).
Frequently asked questions about Cadence Neuroscience
Where is Cadence Neuroscience headquartered?
Cadence Neuroscience, Inc. is headquartered in Sammamish, Washington, United States.
What does Cadence Neuroscience do?
Cadence Neuroscience, Inc. is a biotechnology company.
When was Cadence Neuroscience founded?
The earliest incorporation on record for Cadence Neuroscience, Inc. is in 2017, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences